Evidence map›Paper›PMID 34834129›Full record

ArticleMolecules (Basel, Switzerland)2021

The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90.

Kuan-Chih Wang, Mei-Chin Lu, Kai-Cheng Hsu, Mohamed El-Shazly, Shou-Ping Shih, Ssu-Ting Lien, Fu-Wen Kuo, Shyh-Chyun Yang, Chun-Lin Chen, Yu-Chen S H Yang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Biomimetic Synthesis of Seven Halenaquinone Meroterpenoids.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Kuan-Chih WangSchool of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.ORCID 0000-0002-7482-2459
Mei-Chin LuGraduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.ORCID 0000-0003-4335-3837
Kai-Cheng HsuGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0002-9022-6673
Mohamed El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Organization of African Unity Street, Cairo 11566, Egypt.
Shou-Ping ShihDoctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University (NSYSU), Kaohsiung 804, Taiwan.ORCID 0000-0001-8989-5979
Ssu-Ting LienGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
Fu-Wen KuoGraduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.
Shyh-Chyun YangSchool of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chun-Lin ChenDoctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University (NSYSU), Kaohsiung 804, Taiwan.ORCID 0000-0003-1519-2642
Yu-Chen S H YangJoint Biobank, Office of Human Research, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0002-7589-8527
Taipei Medical University · TWKaohsiung Medical University · TWNational Dong Hwa University · TWNational Sun Yat-sen University · TWAin Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xestoquinone is a polycyclic quinone-type metabolite with a reported antitumor effect. We tested the cytotoxic activity of xestoquinone on a series of hematological cancer cell lines. The antileukemic effect of xestoquinone was evaluated in vitro and in vivo. This marine metabolite suppressed the proliferation of Molt-4, K562, and Sup-T1 cells with IC

Indexed as

AnimalsAntineoplastic AgentsApoptosisCell Line, TumorHSP90 Heat-Shock ProteinsHumansMaleMembrane Potential, MitochondrialMiceMice, NudeMitochondriaQuinonesReactive Oxygen SpeciesSignal TransductionAntineoplastic AgentsHSP90 Heat-Shock ProteinsQuinonesReactive Oxygen SpeciesxestoquinoneanticancerapoptosisHeat shock protein 90 (HSP-90)polycyclic quinonereactive oxygen species (ROS)topoisomerasexestoquinone

Identifiers

PMID34834129
PMCPMC8619641
OpenAlexW3215589683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.